Penny Power Plays – July 14, 2025

July 14, 2025

DENVER, Colo., Jul 14, 2025 (247marketnews.com)- In today’s edition of Penny Power Plays, we’re rounding up key momentum and updates from several familiar names in our penny stock watchlist

Full Alliance Group (OTC:FAGI) just stepped into the decentralized arena with the launch of Qubitera Holdings, an 80%-owned subsidiary focused on blockchain-enabled fintech and healthcare infrastructure.

Partnering with Cooperhead AI, the company aims to deliver an enterprise-grade blockchain ecosystem tailored to healthcare.

The Quant Blockchain will feature HIPAA-compliant data exchange, immutable medical records, and automated billing via smart contracts. Meanwhile, the YAHBEE Wallet positions itself as a Web3-native rival to Cash App and Venmo—with a consumer-focused interface supporting Ethereum, Bitcoin, Solana, and major L2s.

FAGI is this month’s top performer on this list.

BIT Mining (NYSE:BTCM) completed the second phase of its data center acquisition in Ethiopia, now totaling 51 megawatts of mining capacity. This development solidifies BTCM’s role as a rising player in the African crypto infrastructure push.

What’s more notable is BTCM’s pivot toward next-gen chains.

That’s a clear signal that BTCM is aligning with scalable, developer-friendly blockchain layers, potentially making it a surprising Solana play in the coming quarters.

Rani Therapeutics (NASDAQ:RANI) is presenting game-changing preclinical data on its RaniPill robotic capsule, at ENDO 2025 in San Francisco. According to their abstract, “Oral Delivery of a Bispecific GLP-1/GLP-2 Receptor Agonist (PG-102) via a Robotic Pill (RT-114) Achieves Bioequivalence to Subcutaneous Injection in Canines.”

If these bioequivalence results hold in human trials, RANI could redefine oral delivery for weight-loss and metabolic therapies, currently dominated by injectables like Ozempic and Wegovy.

Quick Penny Watchlist Takes

  • Canaan (NASDAQ:CAN): Despite Bitcoin price volatility, Canaan is reportedly eyeing strategic partnerships in Latin America.
  • ProMIS Neurosciences (NASDAQ:PMN): Continues preclinical development on Alzheimer’s antibody PMN310. While early-stage, the science behind misfolded protein targeting remains an intriguing differentiator.
  • Wolfspeed (NYSE:WOLF): Shares rose last week after insider buying and whispers of new EV component deals.
  • VSee Health (NASDAQ:VSEE): Rumors of a major project are swirling.
  • Ondas Holdings (NASDAQ:ONDS): Quietly building momentum in drone infrastructure and AI rail analytics.
  • Safety Shot (NASDAQ:SHOT): Trying to commercialize hangover-prevention formula.

24/7 Market News is paid to publish FAGI’s corporate press releases and editorials.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (FAGI, BTCM, RANI, CAN, PMN, WOLF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.